Fuh KC, Bookman MA, Liu JF, Coleman RL, et al. Phase 1b study of AVB-500 in combination with paclitaxel or pegylated liposomal doxorubicin platinum-resistant recurrent ovarian cancer. Gynecol Oncol 2021 Aug 30. pii: S0090-8258(21)01318.
PMID: 34474927